Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
KOD

KOD - Kodiak Sciences Inc Stock Price, Fair Value and News

$34.07+0.10 (+0.29%)
Market Closed as of 12 Jun 2026, 04:00 pm ET

Price Targets

KOD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

KOD Price Action

Last 7 days

9.7%

Last 30 days

-14.0%

Last 90 days

46.9%

Trailing 12 Months

825.8%

KOD RSI Chart

KOD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

KOD Valuation

Market Cap

2.1B

Price/Earnings (Trailing)

-9.18

EV/EBITDA

-9.21

Price/Free Cashflow

-14.3

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

KOD Fundamentals

KOD Earnings

Earnings (TTM)

-230.7M

Earnings Growth (Yr)

-1.21%

Earnings Growth (Qtr)

-2.51%

KOD Profitability

Return on Equity

-205.76%

Return on Assets

-75.38%

Free Cashflow Yield

-6.99%

KOD Investor Care

Shares Dilution (1Y)

17.83%

Diluted EPS (TTM)

-4.17

KOD Alerts

  • 1 major insider sales recently.

About Kodiak Sciences Inc

KOD
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
 CEO
 WEBSITEhttps://kodiak.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES118

Kodiak Sciences Inc Frequently Asked Questions

KOD is the stock ticker symbol of Kodiak Sciences Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Jun 12 2026, market cap of Kodiak Sciences Inc is 2.12 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.